Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer

NCT02550327 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG: Nab-paclitaxel
DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Anakinra

Sponsor

Baylor Research Institute